(R)-panaxadiol by whole cells of filamentous fungus Absidia coerulea AS 3.3382

J Asian Nat Prod Res. 2018 Aug;20(8):719-726. doi: 10.1080/10286020.2017.1358267. Epub 2017 Sep 25.

Abstract

The microbial transformation of 20(R)-panaxadiol (PD) by the fungus Absidia coerulea AS 3.3382 afforded three new and three known metabolites. The structures of the metabolites were characterized as 3-oxo-20(R)-panaxadiol (1), 3-oxo-7β- hydroxyl-20(R)-panaxadiol (2), 3-oxo-22β-hydroxyl-20(R)-panaxadiol (3), 3-oxo- 7β,22β-dihydroxyl-20(R)-panaxadiol (4), 3-oxo-7β,24β-dihydroxyl-20(R)-panaxadiol (5), and 3-oxo-7β,24α-dihydroxyl-20(R)-panaxadiol (6). Among them, 2-4 were new compounds. In addition, compounds 3 and 4 exhibited significant anti-hepatic fibrosis activity.

Keywords: 20()-panaxadiol; anti-hepatic fibrosis; biotransformation.

MeSH terms

  • Absidia / metabolism*
  • Cell Line
  • Ginsenosides / metabolism*
  • Ginsenosides / therapeutic use*
  • Humans
  • Liver Cirrhosis / drug therapy
  • Molecular Structure
  • NF-kappa B / metabolism
  • Panax notoginseng / chemistry
  • Spectrometry, Mass, Electrospray Ionization

Substances

  • Ginsenosides
  • NF-kappa B
  • panaxadiol